Success Metrics

Active Trials
4(80%)

Phase Distribution

Ph phase_1
4
80%
Ph phase_3
1
20%

Phase Distribution

4

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
4(80.0%)
Phase 3Large-scale testing
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

5

all time

Status Distribution
Active(5)

Detailed Status

Recruiting4
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
4
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 14 (80.0%)
Phase 31 (20.0%)

Trials by Status

not_yet_recruiting120%
recruiting480%

Recent Activity

4 active trials
Showing 5 of 5
recruitingphase_3

A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers

NCT07708753
not_yet_recruitingphase_1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of SYS6043 ± Bevacizumab ± Chemotherapy in Participants With Advanced Solid Tumors

NCT07833735
recruitingphase_1

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

NCT07424547
recruitingphase_1

Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors

NCT07415863
recruitingphase_1

A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors

NCT07241936

Clinical Trials (5)

Showing 5 of 5 trials
NCT07708753Phase 3

A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers

Recruiting
NCT07833735Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of SYS6043 ± Bevacizumab ± Chemotherapy in Participants With Advanced Solid Tumors

Not Yet Recruiting
NCT07424547Phase 1

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

Recruiting
NCT07415863Phase 1

Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors

Recruiting
NCT07241936Phase 1

A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors

Recruiting

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5